SRPT vs STRL · rev $1.90B vs P/E 75, rev $2.12B
Sarepta Therapeutics Inc (SRPT) versus Sterling Construction Company Inc (STRL) — a side-by-side from cached financials, not a winner call.
Sarepta Therapeutics Inc (SRPT) is a biotechnology company listed on US.
Sterling Construction Company Inc (STRL) is a engineering & construction company listed on NASDAQ.
Latest reported SRPT revenue for 2024-12-31 was $1.90B. Net income was $235.2M. Revenue was up 53.0% from 2023-12-31 to 2024-12-31. SRPT currently screens at market cap $2.34B.
Latest reported STRL revenue for 2024-12-31 was $2.12B. Net income was $270.9M. Revenue was up 7.3% from 2023-12-31 to 2024-12-31. STRL currently screens at market cap $25.72B and trailing P/E 75.2.
SRPT currently screens at market cap $2.34B. STRL currently screens at market cap $25.72B and trailing P/E 75.2.
Not investment advice. Open the SRPT and STRL stock pages for the full models.
Not investment advice.